CRO

SGS doubles NJ lab capacity; Pfizer licenses OMT's technology;

> SGS has doubled the size of its labs in Fairfield, NJ, offering 30,000 square feet of laboratory space replete with new equipment for biopharmaceutical development. News

> After a similar deal with WuXi PharmaTech ($WX), Open Monoclonal Technology has licensed its rat models to Pfizer ($PFE) for antibody development. Article

> Quintiles has signed a deal with Comprehensive Clinical Development, giving Comprehensive first refusal to work on Quintiles' sponsored clinical trials. More

> JHP Pharmaceuticals says it has inked an agreement with an undisclosed drugmaker to manufacture a lyophilized biologic for late-stage clinical trials. Story

> AMRI has signed a discovery pact with Knopp Biosciences, agreeing to collaborate on central nervous system drugs. Item